Medartis Holding AGXSWX:MED -0.55%76 FCF Margin % is 6.09% as of Dec. 2025, which is 354% above its 10-year median of 1.34. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.61 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Medartis Holding AG ranks better than 59.26% on this metric.
The historical rank and industry rank for Medartis Holding AG's FCF Margin % or its related term are showing as below:
XSWX:MED'
s FCF Margin % Range Over the Past 10 Years
Min: -12.43 Med: 1.34 Max: 9.33
Current: 3.47
During the past 12 years, the highest FCF Margin % of Medartis Holding AG was 9.33%. The lowest was -12.43%. And the median was 1.34%.
XSWX:MED's FCF Margin % is ranked better than 59.26% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs XSWX:MED: 3.47
Medartis Holding AG FCF Margin % Related Terms
Medartis Holding AG FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Medartis Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a FCF Margin % of 6.09% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medartis Holding AG and its competitors. This is 354% above median its historical median of 1.34. According to the industry distribution chart, Medartis Holding AG ranks #332 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 40.7%.
Is Medartis Holding AG's FCF Margin % too high?
Medartis Holding AG's current FCF Margin % of 6.09% is 354% above median its 10-year median of 1.34. Based on the distribution chart, Medartis Holding AG ranks #332 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #332 out of 815 companies for FCF Margin %. This puts Medartis Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current FCF Margin % is 6.09%, which is 354% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF105.61, compared to a current price of CHF72.00 — trading 31.8% below its estimated fair value. The current FCF Margin % is 6.09%, which is 354% above median its 10-year median of 1.34. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current FCF Margin % is 6.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF72.00 is trading 31.8% below its estimated GF Value™ of CHF105.61.
GuruFocus considers Medartis Holding AG to be Significantly Undervalued.
Key valuation signals for XSWX:MED:
FCF Margin %: 6.09% (354% above median its 10-year median of 1.34)
GF Value™: CHF105.61 vs. price of CHF72.00 (31.8% below fair value)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score
Get the complete analysis for XSWX:MED
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
